Biotech · Private company · Bradenton, FL, US
Continuity Biosciences, LLC
Track this companyFree. Adds Continuity Biosciences, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials11 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- ACT Implantable Iontophoresis Chemotherapy Delivery Device with Gemcitabine (ACT-IOP-003)Phase 1 · Pancreatic Adenocarcinoma Non-resectableClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic CancerPHASE1 · RECRUITING · started Mar 11, 2026ClinicalTrials.gov NCT07481383 · fetched Nov 12, 2026
NIH awards1
- DIRECT TO PHASE II SBIR CONCEPT AWARD FOR NOVEL IONTOPHORETIC DRUG DELIVERY DEVICE FOR LOCAL AND EFFECTIVE TREATMENT OF ORAL CANCERFiscal year 2025 · $3MNIH RePORTER 75N91025C00024-0-9999-1 · fetched Nov 12, 2026